Related Experiment Video
Updated: Mar 23, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular
María Llanos Valero1, Rosario Sabariegos2, Francisco J Cimas3
1Laboratorio de Virología Molecular, Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla-La Mancha, Albacete, Spain.
Abstract:
Hepatitis C virus (HCV) interacts with cellular components and modulates their activities for its own benefit. These interactions have been postulated as a target for antiviral treatment, and some candidate molecules are currently in clinical trials. The multifunctional cellular kinase Akt/protein kinase B (PKB) must be activated to increase the efficacy of HCV entry but is rapidly inactivated as the viral replication cycle progresses. Viral components have been postulated to be responsible for Akt/PKB inactivation, but the underlying mechanism remained elusive. In this study, we show that HCV polymerase NS5B interacts with Akt/PKB. In the presence of transiently expressed NS5B or in replicon- or virus-infected cells, NS5B changes the cellular localization of Akt/PKB from the cytoplasm to the perinuclear region. Sequestration of Akt/PKB by NS5B could explain its exclusion from its participation in early Akt/PKB inactivation. The NS5B-Akt/PKB interaction represents a new regulatory step in the HCV infection cycle, opening possibilities for new therapeutic options.
Insights
Hepatitis C virus (HCV) polymerase NS5B sequesters Akt/protein kinase B (PKB), altering its location. This interaction reveals a new mechanism in HCV infection and potential therapeutic targets.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Hepatitis C virus (HCV) manipulates host cell functions for replication.
- Akt/protein kinase B (PKB) activation is crucial for HCV entry, but its inactivation during the viral cycle is not fully understood.
- Viral factors are suspected to cause Akt/PKB inactivation, yet the mechanism remains elusive.
Purpose of the Study:
- To elucidate the mechanism behind Akt/PKB inactivation during HCV infection.
- To identify the specific viral component responsible for modulating Akt/PKB activity.
- To explore the implications of this interaction for novel antiviral strategies.
Main Methods:
- Expression of HCV polymerase NS5B in cell culture.
- Analysis of Akt/PKB cellular localization in the presence of NS5B.
- Investigation in HCV replicon and virus-infected cells.
Main Results:
- HCV polymerase NS5B directly interacts with Akt/PKB.
- NS5B alters Akt/PKB's cellular localization from the cytoplasm to the perinuclear region.
- This NS5B-induced sequestration may explain Akt/PKB's exclusion from early inactivation events.
Conclusions:
- The interaction between HCV NS5B and Akt/PKB is a novel regulatory step in the HCV life cycle.
- NS5B-mediated sequestration of Akt/PKB offers a new perspective on HCV pathogenesis.
- This interaction presents a potential target for developing new anti-HCV therapeutics.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
PI3K/mTOR/AKT Signaling Pathway
RNA Polymerase II Accessory Proteins

